Sequences of BE study under both fasting and fed studies [Design Issues]

posted by ElMaestro  – Denmark, 2025-09-04 10:05 (273 d 08:50 ago) – Posting: # 24438
Views: 3,704

Hi A. Shtaiwi,

❝ Which approach would regulators (e.g. EMA) accept?


In my experience option 2 has been rather commonly used and accepted.
The others may be as well but I don't have a lot of experience.

❝ Also, would the same logic apply to studies of orally inhaled products where we compare “with charcoal” vs “without charcoal” (instead of fasting vs fed)?


In my experience, yes. But I think companies tend to start with the "without charcoal" matter first.

There could be national preferences. I mean, if you approach DE and SE for sc. advice then they might not have exactly the same opinion or preference.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
435 visitors (0 registered, 435 guests [including 18 identified bots]).
Forum time: 18:55 CEST (Europe/Vienna)

I’m all in favor of the democratic principle
that one idiot is as good as one genius, but I draw the line
when someone takes the next step and concludes
that two idiots are better than one genius.    Leo Szilard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5